Announcements Trials

Browse Landscape

Phase

Status

Completed 43 Recruiting 11 Active not recruiting 11 Terminated 9 Withdrawn 4 Unknown 4 Not yet recruiting 3 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5 Other hematologic neoplasm 1 Gynecologic 1 Breast 1

Conditions

Peritoneal Neoplasms 1

Interventions

Nivolumab 3 Interviews as Topic 2 taxane 1 palbociclib 1 gedatolisib 1 aldesleukin 1 X-Rays 1 Specimen Handling 1 Quality of Life 1 Phantoms, Imaging 1 Pemetrexed 1 Paclitaxel 1 Nutritional Status 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Interleukin-2 1 Infusions, Parenteral 1 Hyperthermic Intraperitoneal Chemotherapy 1 E-3810 1 Doxorubicin 1 Cisplatin 1 CTLA-4 Antigen 1 Blood Transfusion 1 Blood Specimen Collection 1 Biopsy 1 Behavior Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Doxorubicin × Gynecologic × Clear all

NCT03875144 2026-02-09

MESOTIP

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 2 Suspended

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡